Olgram is a private biotechnology company located in Britany, France that specializes in the development of molecules to fight against antibiotic resistance.
Objectives and mission:
The principal activity of Olgram is the development of novel molecules for the prevention and fight of bacterial infections. The company tackles this problematic from 2 sides: It develops molecules that boost the immune system of the host and also a new class of antibiotics. Olgram will develop highly effective and safe antibacterial and immune system stimulant to answer to the pressing and urging need to find new solutions to fight against antibiotic resistance. Our goal is to carry out initial development studies and early stage clinical testing in order to produce candidates that are attractive for further development.